The Enterprise Value as of September 2024 (TTM) for Vir Biotechnology, Inc. (VIR) is 864.03M

According to Vir Biotechnology, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 864.03M. This represents a change of -23.44% compared to the average of 1.13B of the last 4 quarters.

Vir Biotechnology, Inc. (VIR) Historical Enterprise Value (quarterly & annually)

How has VIR Enterprise Value performed in the past?

The mean historical Enterprise Value of Vir Biotechnology, Inc. over the last ten years is 2.23B. The current 864.03M Enterprise Value has changed 3.77% with respect to the historical average. Over the past ten years (40 quarters), VIR's Enterprise Value was at its highest in in the March 2021 quarter at 6.10B. The Enterprise Value was at its lowest in in the June 2018 quarter at 0.

Vir Biotechnology, Inc. (VIR) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Vir Biotechnology, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Vir Biotechnology, Inc. (VIR) Average Enterprise Value

How has VIR Enterprise Value performed in the past?

The current Enterprise Value of Vir Biotechnology, Inc. (VIR) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Vir Biotechnology, Inc. (VIR) Enterprise Value vs. Peers

How is VIR’s Enterprise Value compared to its peers?

Vir Biotechnology, Inc.’s Enterprise Value is greater than CureVac N.V. (390.67M), less than Reata Pharmaceuticals, Inc. (6.68B), less than Krystal Biotech, Inc. (4.95B), greater than Propanc Biopharma, Inc. (1.07M), less than IVERIC bio, Inc. (5.14B), less than Blueprint Medicines Corporation (6.16B), greater than Amylyx Pharmaceuticals, Inc. (89.50M), less than Karuna Therapeutics, Inc. (12.43B), less than Day One Biopharmaceuticals, Inc. (1.01B), less than Viking Therapeutics, Inc. (5.95B), less than Intercept Pharmaceuticals, Inc. (915.81M), greater than Terns Pharmaceuticals, Inc. (458.36M), less than Akero Therapeutics, Inc. (1.56B), less than PTC Therapeutics, Inc. (2.17B), less than Madrigal Pharmaceuticals, Inc. (4.91B),

Build a custom stock screener for Vir Biotechnology, Inc. (VIR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vir Biotechnology, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Vir Biotechnology, Inc. (VIR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Vir Biotechnology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.